Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications ...

Casper Sek of Jingtian & Gongcheng examines the evolution and refinement of China’s data protection oversight throughout 2024 ...

Simon Leung, Partner of Baker McKenzie, and Terry Xu, Senior Counsel at FenXun Partners, examine key regulatory shifts in 2024 and provide an outlook of potential regulatory trends for the banking and ...

Chinese EV maker Geely expands into Brazil through a partnership with France’s Renault; The parent company of Calvin Klein and Tommy Hilfiger is blacklisted by China; and Canadian Solar is sued by ...

Casper Sek and Alan Zhang of Jingtian & Gongcheng provide answers to key questions on China’s data transfer regime, and identify some vital trends “There are typically no specific restrictions on the ...

China Law & Practice Awards 2024 sees a broad spectrum of law firms seize crown in individual practices. Fangda Partners and Clifford Chance win top accolades in the 18th annual CLP Awards.

In the News: PVH Investigated Over Quitting Xinjiang; Chinese WuXi Seeks Buyers For US Business; Draft Law to Protect Private Sector ...

In 2024, China’s legislation responded to various social hotspots and addressed some typical issues in judicial practices. The implementation of the New Company Law further enhanced shareholder ...

SAMR issues the first official document on anti-corruption guidance for the healthcare sector. Data centers are required to safeguard the security of the customer’s own training datasets. Regulatory ...

Main contents: Where the deadline for the outstanding subscribed-for capital contributions to a limited liability company registered and established on or before June 30, 2024 is greater than five ...